framework contract for the supply of the latest approved protein based COVID-19 vaccines

at the vaccine is adapted to the relevant variants for the European Union population and ensure availability of adapted vaccines in accordance with the most recent Experts recommendations on the need for updating the strain composition of C19 vaccines. The necessity of adapting the vaccine shall be

assessed at least yearly, on time, to start timely distribution of updated vaccines for vaccination during second half of the year, unless other timing of updates is considered necessary. The contractor shall also ensure any other relevant